Indraprastha Medical Delivers Healthy Q4 Surge With Robust Margins And Steady Dividend

Nikunj Parikh - Mumbai Bureau May 12, 2026 9,700 Views

Indraprastha Medical Corporation Limited (Indraprastha Apollo Hospitals) reported a strong Q4 FY26 performance with healthy revenue growth, stable profitability and a maintained dividend payout, underscoring its resilient healthcare business and steady cash flows. The company remains focused on operational efficiency, clinical excellence and disciplined capital allocation to drive long-term value for shareholders.

Indraprastha Medical Corporation Limited has approved its audited financial results for the quarter and year ended 31 March 2026, alongside a recommended dividend of 4 rupees per share for FY25-26, subject to shareholder approval. The board met on 12 May 2026 to review and adopt the results, with auditors issuing an unmodified opinion on the annual financial statements.

Quarterly Performance Snapshot

For Q4 FY26, revenue from operations stood at 364.81 crore rupees, up from 333.75 crore rupees in the same quarter last year, reflecting sustained growth in core healthcare services. Profit after tax for the quarter was 41.70 crore rupees, broadly stable versus 41.01 crore rupees in Q4 FY25, supported by disciplined cost management and strong doctor and employee productivity.

Full-Year FY26 Financial Performance

For FY26, revenue from operations rose to 1,482.51 crore rupees from 1,356.36 crore rupees in FY25, while profit after tax increased to 183.62 crore rupees from 160.99 crore rupees, indicating improved profitability. Total comprehensive income for the year reached 184.94 crore rupees, and earnings per share for FY26 stood at 20.03 rupees (basic and diluted), compared with 17.56 rupees in the previous year. The company reported robust other income of 28.75 crore rupees and maintained strong operating margins with total expenses of 1,265.24 crore rupees on total income of 1,511.26 crore rupees.

Balance Sheet Strength And Cash Flows

As of 31 March 2026, total assets stood at 991.36 crore rupees, with equity (share capital plus other equity) at 740.37 crore rupees, reflecting a solid capital base. Cash flow from operations for FY26 was 167.44 crore rupees, demonstrating strong internal cash generation despite higher investments in property, plant and equipment and financial assets. The company continued to invest in healthcare infrastructure and financial instruments, with non-current financial assets at 203.50 crore rupees and property, plant and equipment at 330.96 crore rupees as of year end.

Key Highlights

Revenue from operations Q4 FY26 364.81 crore rupees; FY26 1,482.51 crore rupees
Q4 FY26 PAT 41.70 crore rupees; FY26 PAT 183.62 crore rupees
Dividend recommended 40 percent, 4 rupees per equity share for FY25-26 (previous year 4.50 rupees)
FY26 earnings per share 20.03 rupees versus 17.56 rupees in FY25
Total assets 991.36 crore rupees; equity 740.37 crore rupees as of 31 March 2026
Auditors issued an unmodified opinion on FY26 financial results

Sources: Indraprastha Medical Corporation Limited Q4 and FY26 audited financial results and board meeting outcome filing

Stay Ahead – Explore Now! Alkem Labs Launches Renocia Exo Hair Growth Serum